The global single nucleotide polymorphism (SNP) genotyping market size was valued at USD 7.24 billion in 2025 and is predicted to hit around USD 19.48 billion by 2034, rising at a 11.7% CAGR, a study ...
SNP-SNP interactions and a 4-locus model for prediction the risk of anthracycline-mediated cardiotoxicity in patients with breast cancer. This is an ASCO Meeting Abstract from the 2022 ASCO Annual ...
CMD-related SNPs. CMD, coronary microvascular dysfunction; SNP, single nucleotide polymorphism. The findings suggest that a genetics-driven approach could revolutionize CMD diagnosis and treatment, ...
In vitro and in vivo activities of KRN330, a fully human monoclonal antibody against colon cancer. Background: Neoadjuvant fluoropyrimidine-based chemotherapy (ChT) plus radiotherapy (Rt) is a ...
Using SNP-CGH to Profile for Amplifications, Duplications, and Deletions The beginnings of personalized medicine have been forged by recent advances in SNP genotyping technologies. It is now possible ...
1982 The Human Polymorphism Study Center, the first academic institution to propose the systematic study of polymorphisms, is founded in Paris. Its primary objective: to make an inventory of all ...
About 50% of patients with lung cancer present with metastatic disease; researchers have shown that breast cancer metastasis-suppressor 1 (BRMS1) suppresses metastases in non-small-cell lung cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results